Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Atlantis Healthcare and Amgen Take Home Two Prestigious Pharmaceutical Market Excellence Awards (PMEA) for their On Path Patient Support Program


LONDON, November 23, 2017 /PRNewswire/ --

Atlantis Healthcare, global leader in outcomes-driven healthcare solutions, is proud to have won two awards for its 'On Path' program at last week's PMEA pharmaceutical industry awards. This innovative patient support program (PSP) was developed in partnership with Amgen UK.

Matthew Walls, Chairman and CEO, Atlantis Healthcare said: "We are delighted to be awarded both the 'Excellence in Patient Education and Support' and 'Excellence in Marketing New Products' awards for the On Path program."

"Winning these prestigious awards is wonderful recognition of our unique approach to PSPs that drive improved self-management and increase medicine adherence."

The judges said: "This impressive entry is a strong behavioral change program that was coupled with real-life involvement and insightful clinical feedback. It is exceptional to see the program gain wide adoption by the NHS. Their patient adherence outcomes were striking."  

More about the multi-award winning On Path program  

On Path is a unique multi-channel PSP based on health psychology principles developed by Atlantis Healthcare for Amgen. It supports successful treatment initiation and promotes persistence through:

On Path has had a positive impact on treatment persistence, confidence in treatment administration and reduction in injection concerns. Patients indicated a high degree of satisfaction with the program.

Richard Wadrup, Senior Marketing Manager, Cardiovascular, Amgen commented: "The program results were really encouraging. This accolade is a very well-deserved recognition of the strong partnership between the two companies in helping to improve the lives of patients with hypercholesterolemia."

In addition to winning these awards, the On Path program was shortlisted as a finalist for the 'Excellence in Creating Value Beyond the Product' award. For more information see: http://bit.ly/2z72jb7.

About Atlantis Healthcare 

Atlantis Healthcare has offices in UK, Germany, Spain, US, Australia and New Zealand. Its health psychology, creative and digital expertise supports the design of highly personalized healthcare solutions that drive optimal health outcomes.

It uses clinically proven models and academic research to develop award-winning behavior change programs at global, regional and local levels.

To find out more visit: www.atlantishealthcare.com

For further details about Atlantis Healthcare's work and services contact: Sarah Vine, Director of Strategy ([email protected] ), +44-20-8747-4360


These press releases may also interest you

at 04:00
Yukon Group, Europe's leading thermal imaging and night vision company, has launched the world's first upgradable thermal monocular for civilian use. The Pulsar Telos LRF XP50 is set to become an indispensable tool for hunters, explorers and rescuers...

at 04:00
Growing Bolder, a leading lifestyle content producer, and OTT Advisors (OTTA), a leading advisory service for digital strategy, are partnering to launch the world's first active-lifestyle streaming platform for the world's fastest-growing and most...

at 03:40
KLab Inc. announced that its hit 3D action game Bleach: Brave Souls will be holding the Thousand-Year Blood War Zenith Summons: Reinforcements from Sunday, March 31. See the original press release (https://www.klab.com/en/press/) for more...

at 03:30
Electric vehicles (EVs) are a primary method to reach a net zero transportation sector, but in addition to CO2 emissions, overall sustainability is becoming an increased focus point. However, sustainability is a very complex topic that does not tend...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:23
The total number of votes in EQT AB (publ) ("EQT") changed during March 2024 as a result of a conversion of 348,106 class C shares to 348,106 ordinary shares. The conversion was made pursuant to EQT's previous Share Program. The total...



News published on and distributed by: